Skip to main content

Entelos Picks Platform Computing for Processing Software

SAN FRANCISCO, Dec. 6 - Entelos will integrate Toronto-based Platform Computing's distributed platform software into its PhysioLab disease simulation technology, the companies have announced.


The software, Platform LSF and Platform LSF ActiveCluster, allow Menlo Park, Calif.-based Entelos to manage workloads across its server farms and distribute its desktop processing.


Financial details of the agreement, made public on Wednesday, were not disclosed.


"Platform LSF ActiveCluster was a deciding factor [in the purchase] -- with ActiveCluster we can go beyond traditional distributed computing and expand our processing power by utilizing idle desktops," Alex Bangs, chief technology officer at Entelos, said in a statement. "As we plan to offer this technology to our pharmaceutical partners, this will provide as significant a benefit to them as it will to us."

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.